| K. Danfelt Llc Dba Berry Sweet Speech & Language | |
|
1733 San Gabriel Dr, York, PA 17406-1814 | |
| (717) 880-7131 | |
| Not Available |
| Full Name | K. Danfelt Llc Dba Berry Sweet Speech & Language |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 1733 San Gabriel Dr, York, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063296440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| K. Danfelt Llc Dba Berry Sweet Speech & Language 1733 San Gabriel Dr, York, PA 17406-1814 Ph: (717) 880-7131 | K. Danfelt Llc Dba Berry Sweet Speech & Language 1733 San Gabriel Dr, York, PA 17406-1814 Ph: (717) 880-7131 |
News Archive
New research offers unprecedented insights into the causes of childhood diarrhea, the second-leading cause of death of children worldwide, and suggests that the role of pathogens such as bacteria, viruses and parasites has been vastly underestimated.
Depression takes a substantial toll on brain health. Brain imaging and post-mortem studies provide evidence that the wealth of connections in the brain are reduced in individuals with depression, with the result of impaired functional connections between key brain centers involved in mood regulation. Glial cells are one of the cell types that appear to be particularly reduced when analyzing post-mortem brain tissue from people who had depression.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
NeuroDerm, Ltd. was informed today that it was awarded, for the second time, a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research to support the clinical development of its subcutaneously delivered drug for the treatment of Parkinson's disease.
Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
› Verified 9 days ago
Sandra Lynn Harberger, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 E Market St Ste B, York, PA 17402 Phone: 717-364-7778 Fax: 717-382-0196 | |
Mrs. Karen Smay Fry, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 S George St, York, PA 17403 Phone: 717-851-2601 Fax: 717-851-4618 | |
Marci Jo Merlina, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1802 Folkemer Cir, York, PA 17404 Phone: 717-767-0580 | |
Ms. Margaret L. Whitehead-bien, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 E Market St, York, PA 17402 Phone: 717-751-2758 | |
Rachael Franklin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3995 E Market St, York, PA 17402 Phone: 717-757-1227 | |
Mrs. Sarah Fee Peters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Memory Lane Ext, York, PA 17402 Phone: 717-757-5433 | |
Miwon Susan Trone, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Monument Rd Ste 175, York, PA 17403 Phone: 717-479-0604 |